TITLE

Dysphagia in Inflammatory Myopathy: Clinical Characteristics, Treatment Strategies, and Outcome in 62 Patients

AUTHOR(S)
Oh, Terry H.; Brumfield, Kathlyn A.; Hoskin, Tanya L.; Stolp, Kathryn A.; Murray, Joseph A.; Basford, Jeffrey R.
PUB. DATE
April 2007
SOURCE
Mayo Clinic Proceedings;Apr2007, Vol. 82 Issue 4, p441
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE: To assess the clinical characteristics, treatment, and outcome of patients with inflammatory myopathy-associated dysphagia. PATIENTS AND METHODS: We retrospectively reviewed the medical records of all patients with inflammatory myopathy-associated dysphagia seen at the Mayo Clinic in Rochester, Minn, between January 1, 1997, and December 31, 2001. RESULTS: A total of 783 patients were diagnosed as having inflammatory myopathy during the 5-year study period. Of these, 62 patients (41 women and 21 men; mean age, 68.6 years) had inflammatory myopathy-associated dysphagia: 26 with inclusion body myositis (IBM), 18 with dermatomyositis, 9 with polymyositis, and 9 with overlap syndrome. Dysphagia was a presenting symptom in 13 patients (21%), with the highest incidence in the IBM group. Videofluoroscopic examinations revealed pharyngeal pooling and impaired oropharyngeal and cricopharyngeal function. The benefits of swallowing compensation techniques and exercises were difficult to establish. Interventional procedures were performed in 24 patients (39%) and most frequently (62%) in patients with IBM, with cricopharyngeal myotomy being most beneficial. Patients with IBM had the least symptomatic improvement. Overall, 11 patients died during the median follow-up of 38 months, with respiratory failure due to aspiration pneumonia as the most common cause. Mortality was high in patients who required percutaneous endoscopic gastrostomy (7/11, 64%), and 1-year mortality was highest (31%) in those with dermatomyositis. CONCLUSION: Dysphagia is a serious and at times presenting problem in patients with inflammatory myopathy. It occurs most frequently and appears to be most refractory in patients with IBM. The mortality rate was high in patients who required percutaneous endoscopic gastrostomy, and the 1-year mortality rate was the highest in patients with dermatomyositis.
ACCESSION #
24851317

 

Related Articles

  • Dysphagia Due to Inclusion Body Myositis: Case Presentation and Review of the Literature. Ko, Ellen H.; Rubin, Adam D. // Annals of Otology, Rhinology & Laryngology;Sep2014, Vol. 123 Issue 9, p605 

    Objective: This report aimed to present a case of inclusion body myositis presenting with dysphagia and to review the literature. Methods: Case report and literature review. Results: Inclusion body myositis is a chronic progressive acquired myopathy, uniquely distinguished by its selective...

  • A dysphagia study in patients with sporadic inclusion body myositis (s-IBM). Murata, Ken-ya; Kouda, Ken; Tajima, Fumihiro; Kondo, Tomoyoshi // Neurological Sciences;Aug2012, Vol. 33 Issue 4, p765 

    The nature of the swallowing impairment in patients with sporadic inclusion body myositis (s-IBM) has not been well characterized. In this study, we examined ten consecutive s-IBM patients using videofluoroscopy (VF) and computed pharyngoesophageal manometry (CPM). The patients were divided into...

  • Inclusion body myositis. Badrising, Umesh A.; Maat-Schieman, Marion L. C.; van Houwelingen, Johannes C.; van Doorn, Pieter A.; van Duinen, Sjoerd G.; van Engelen, Baziel G. M.; Faber, Carin G.; Hoogendijk, Jessica E.; de Jager, Aeiko E.; Koehler, Peter J.; de Visser, Marianne; Verschuuren, Jan J. G. M.; Wintzen, Axel R. // Journal of Neurology;Dec2005, Vol. 252 Issue 12, p1448 

    The clinical features of inclusion body myositis (IBM) were of minor importance in the design of consensus diagnostic criteria, mainly because of controversial views on the specificity of signs and symptoms, although some authors reported "typical" signs. To re–assess the clinical...

  • An Italian family with autosomal recessive quadriceps-sparing inclusion-body myopathy (ARQS-IBM) linked to chromosome 9p1. Mirabella, M.; Christodoulou, K.; Di Giovanni, S.; Ricci, E.; Tonali, P.; Servidei, S. // Neurological Sciences;Apr2000, Vol. 21 Issue 2, p99 

    We report an Italian family with autosomal recessive quadriceps-sparing inclusion-body myopathy (ARQS-IBM). The patients (two second cousins) developed a slowly progressive distal and proximal myopathy with complete sparing of the quadriceps. Muscle biopsy showed rimmed vacuoles in numerous...

  • Amyloid Myoneuropathy Mimicking Inclusion Body Myositis. Abuzinadah, Ahmad R.; Joseph, Jeffrey T.; Korngut, Lawrence // Canadian Journal of Neurological Sciences;Mar2013, Vol. 40 Issue 2, p255 

    The article presents a case study of a 59-year-old right-handed man with progressive weakness over five years. Motor examination has revealed no wasting, fasciculations, pseudohypertrophy or scapular winging. The article discusses gradually progressive weakness with an asymmetric distal-proximal...

  • Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features. Brady, Stefen; Squier, Waney; Hilton-Jones, David // Journal of Neurology, Neurosurgery & Psychiatry;Nov2013, Vol. 84 Issue 11, p1240 

    Background and objective: Historically, the diagnosis of sporadic inclusion body myositis (IBM) has required the demonstration of the presence of a number of histopathological findings on muscle biopsy--namely, rimmed vacuoles, an inflammatory infiltrate with invasion of non-necrotic muscle...

  • Inclusion body myositis - pathomechanism and lessons from genetics. Murnyák, Balázs; Bodoki, Levente; Vincze, Melinda; Griger, Zoltán; Csonka, Tamás; Szepesi, Rita; Andrea Kurucz; Dankó, Katalin; Hortobágyi, Tibor // Open Medicine;2015, Vol. 10 Issue 1, p-1 

    Inclusion body myositis is a rare, late-onset myopathy. Both inflammatory and myodegenerative features play an important role in their pathogenesis. Overlapping clinicopathological entities are the familial inclusion body myopathies with or without dementia. These myopathies share several...

  • Valosin-containing protein and the pathogenesis of frontotemporal dementia associated with inclusion body myopathy. Guinto, Jake; Ritson, Gillian; Taylor, J.; Forman, Mark // Acta Neuropathologica;Jul2007, Vol. 114 Issue 1, p55 

    Frontotemporal dementia with inclusion body myopathy and Paget’s disease of bone (IBMPFD) is a rare, autosomal dominant disorder caused by mutations in the gene valosin-containing protein ( VCP). The CNS pathology is characterized by a novel pattern of ubiquitin pathology distinct from...

  • Vacuolar myopathy in a dog resembling human sporadic inclusion body myositis. King, Jason; LeCouteur, Richard A.; Aleman, Monica; Williams, D. Colette; Moore, Peter F.; Guo, Ling T.; Mizisin, Andrew P.; Shelton, G. Diane // Acta Neuropathologica;Nov2009, Vol. 118 Issue 5, p711 

    Sporadic inclusion body myositis (sIBM) is the most common myopathy in people over the age of 50 years. While immune-mediated inflammatory myopathies are well documented in dogs, sIBM has not been described. An 11-year-old dog with chronic and progressive neuromuscular dysfunction was evaluated...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics